Renal Angiomyolipoma (AML): Benign Kidney Tumor – Symptoms & Management

What Is an AML?

Renal angiomyolipoma is a benign mesenchymal tumor composed of abnormal blood vessels, smooth muscle, and adipose tissue. Most are sporadic; 20% associated with tuberous sclerosis complex (TSC) (often bilateral, multiple, larger).

Clinical Presentation

  • Asymptomatic (majority): Incidental on imaging for other reasons.
  • Symptomatic (larger, typically >4 cm):
    • Flank/abdominal pain (stretching of capsule)
    • Hematuria (microscopic or gross)
    • Hypertension (renin secretion or vascular compression)
    • Retroperitoneal hemorrhage (Wunderlich syndrome) – life-threatening, presents with acute pain, hypotension.

Risk of Kidney Failure

Very low for solitary, small AML. Risk increases with:

  • TSC-associated, multiple/bilateral tumors
  • Large tumors (>4 cm) compressing renal parenchyma
  • Coexisting CKD, diabetes, hypertension
  • Recurrent hemorrhage requiring embolization/nephrectomy

Management

ScenarioApproach
Small (<4 cm), asymptomatic, sporadicActive surveillance: US/CT q6–12mo initially, then annually
>4 cm or growingConsider intervention (embolization preferred; partial nephrectomy if feasible)
Symptomatic (pain, hematuria)Embolization (selective arterial) or surgery
Acute hemorrhageEmergent embolization; nephrectomy if unstable
TSC-associatedmTOR inhibitors (sirolimus/everolimus) can shrink tumors; multidisciplinary care

Follow-Up

Regular imaging + renal function (eGFR, BP, urinalysis). Genetic counseling if TSC suspected.

Kidney Disease - Related Articles